Tectonic Therapeutic
TECX
105 hedge funds and large institutions have $494M invested in Tectonic Therapeutic in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 45 increasing their positions, 20 reducing their positions, and 12 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 20
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
23% more capital invested
Capital invested by funds: $403M → $494M (+$90.8M)
4% more funds holding
Funds holding: 101 → 105 (+4)
0.1% less ownership
Funds ownership: 7.23% → 7.13% (-0.1%)
11% less call options, than puts
Call options by funds: $241K | Put options by funds: $270K
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$19.8M |
| 2 |
JP Morgan Chase
New York
|
+$12.9M |
| 3 |
DM
Deerfield Management
New York
|
+$11.9M |
| 4 |
BlackRock
New York
|
+$9.86M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.8M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.11M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.89M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.78M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.69M |
TECX Hedge Fund Activity: Q4 2020 in Review
105 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2020, worth a combined $494M — up 23% from $403M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TECX positions and 12 closed out — a net gain of 4 holders — while 45 added to existing stakes and 20 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $19.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $12.8M.
- 105 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2020, up from 101 in Q3 2020.
- Funds reported $494M of Tectonic Therapeutic stock for Q4 2020, up 23% quarter-over-quarter.
- 16 funds opened new Tectonic Therapeutic positions in Q4 2020 and 12 closed out, a net change of +4 holders.
- The largest Tectonic Therapeutic buyer in Q4 2020 was Camber Capital Management, an estimated $19.8M added.
- The largest Tectonic Therapeutic seller in Q4 2020 was T. Rowe Price Associates, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2020.